Geneos Wealth Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$835K Sell
48,000
-2,000
-4% -$31.9K 0.02% 633
2026
Q2
$785K Hold
50,000
– – 0.02% 599
2026
Q1
$414K Sell
50,000
-10,000
-17% -$90.3K 0.01% 752
2025
Q4
$576K Hold
60,000
– – 0.01% 630
2025
Q3
$569K Hold
60,000
– – 0.01% 617
2025
Q2
$448K Hold
60,000
– – 0.01% 744
2025
Q1
$365K Hold
60,000
– – 0.01% 726
2024
Q4
$467K Hold
60,000
– – 0.02% 608
2024
Q3
$487K Hold
60,000
– – 0.02% 574
2024
Q2
$415K Buy
+60,000
New +$808K 0.02% 539
2021
Q4
– Sell
-877
Closed -$57K – 2789
2021
Q3
$57K Hold
877
– – ﹤0.01% 1416
2021
Q2
$54K Hold
877
– – ﹤0.01% 1435
2021
Q1
$49K Hold
877
– – ﹤0.01% 1641
2020
Q4
$45K Buy
877
+163
+23% +$7.76K ﹤0.01% 1499
2020
Q3
$33K Buy
714
+255
+56% +$10.3K ﹤0.01% 1423
2020
Q2
$13K Buy
+459
New +$10.2K ﹤0.01% 1795

Other funds holding CYRX

Geneos Wealth Management's CYRX Position: Q3 2026 in Review

Geneos Wealth Management reduced its CryoPort (CYRX) stake by 4% in Q3 2026, selling an estimated $31.9K and leaving 48,000 shares worth $835K. The position accounts for 0.02% of the portfolio, ranked #633.

Geneos Wealth Management first reported a position in CYRX in Q2 2020 and has held it in 16 quarters since. 195 funds tracked by Wall St. Rank hold CYRX as of Q3 2026.

  • Geneos Wealth Management held 48,000 shares of CryoPort worth $835K as of Q3 2026.
  • Geneos Wealth Management sold 2,000 CryoPort shares in Q3 2026, an estimated $31.9K.
  • CryoPort made up 0.02% of Geneos Wealth Management's portfolio in Q3 2026, its #633 holding.
  • Geneos Wealth Management first reported a position in CryoPort in Q2 2020 and has held it in 16 quarters since.
  • 195 funds tracked by Wall St. Rank held CryoPort as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.